| NCT ID | NCT07540143 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 350 participants |
| Start Date | 2026-06-16 |
| Primary Completion | 2029-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 350 participants in total. It began in 2026-06-16 with a primary completion date of 2029-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Test the effectiveness of a technology-enabled strategy to optimize blood pressure among reproductive-aged women with hypertension receiving care in Federally Qualified Health Centers.
Eligibility Criteria
Inclusion Criteria: * biologically female * age 18-44 * English or Spanish-speaking * prescribed an antiHTN * have a systolic BP \>140 or diastolic BP\>90 at their index visit * have access to the internet Exclusion Criteria: * not pregnant or within 3 months postpartum * severe, uncorrectable vision, hearing, or cognitive impairment that would preclude study consent or participation
Contact & Investigator
Stacy C Bailey, PhD, MPH
PRINCIPAL INVESTIGATOR
Northwestern University
Frequently Asked Questions
Who can join the NCT07540143 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 44 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07540143 currently recruiting?
Yes, NCT07540143 is actively recruiting participants. Contact the research team at stacy-bailey@northwestern.edu for enrollment information.
Where is the NCT07540143 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT07540143 clinical trial?
NCT07540143 is sponsored by Northwestern University. The principal investigator is Stacy C Bailey, PhD, MPH at Northwestern University. The trial plans to enroll 350 participants.